{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:21:12Z","timestamp":1783052472230,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04390-8","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:57:00Z","timestamp":1778507820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant chemotherapy and lymph node examination interact to shape survival in older adults (\u2265\u200975 years) with resected gastric cancer: a SEER-based propensity score\u2013matched and competing-risk analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiajun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"3","key":"4390_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"10251","key":"4390_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"key":"4390_CR3","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1\u201325.","DOI":"10.1007\/s10120-022-01331-8"},{"issue":"18","key":"4390_CR4","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810\u201320.","journal-title":"N Engl J Med"},{"issue":"9813","key":"4390_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321.","journal-title":"Lancet"},{"issue":"10","key":"4390_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"4390_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"10184","key":"4390_CR8","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet"},{"issue":"17","key":"4390_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.2010.534","volume":"303","author":"X Paoletti","year":"2010","unstructured":"Paoletti X, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010;303(17):1729\u201337.","journal-title":"JAMA"},{"issue":"27","key":"4390_CR10","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","volume":"341","author":"LF Hutchins","year":"1999","unstructured":"Hutchins LF, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061\u20137.","journal-title":"N Engl J Med"},{"issue":"22","key":"4390_CR11","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","volume":"291","author":"VH Murthy","year":"2004","unstructured":"Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720\u20136.","journal-title":"JAMA"},{"key":"4390_CR12","doi-asserted-by":"crossref","unstructured":"Lewis JH et al. Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials. J Clin Oncol. 21(7):1383\u20139.","DOI":"10.1200\/JCO.2003.08.010"},{"issue":"25","key":"4390_CR13","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","volume":"29","author":"A Hurria","year":"2011","unstructured":"Hurria A, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457\u201365.","journal-title":"J Clin Oncol"},{"issue":"22","key":"4390_CR14","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol. 2018;36(22):2326\u201347.","journal-title":"J Clin Oncol"},{"issue":"28","key":"4390_CR15","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1200\/JCO.2005.14.621","volume":"23","author":"DD Smith","year":"2005","unstructured":"Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23(28):7114\u201324.","journal-title":"J Clin Oncol"},{"issue":"11","key":"4390_CR16","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389\u2013430.","journal-title":"Stat Med"},{"issue":"16","key":"4390_CR17","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/sim.4264","volume":"30","author":"X Zhang","year":"2011","unstructured":"Zhang X, Zhang MJ, Fine J. A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data. Stat Med. 2011;30(16):1933\u201351.","journal-title":"Stat Med"},{"issue":"1","key":"4390_CR18","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12672-025-02375-9","volume":"16","author":"F Ma","year":"2025","unstructured":"Ma F, et al. Survival benefits of postoperative adjuvant chemotherapy in adults aged\u2009\u2265\u200980 years with locally advanced gastric cancer: insights from a population-based study. Discov Oncol. 2025;16(1):653.","journal-title":"Discov Oncol"},{"key":"4390_CR19","doi-asserted-by":"crossref","unstructured":"Chan WL, et al. Adjuvant Chemotherapy in Older Patients with Gastric Cancer: A Population-Based Cohort Study. Cancers (Basel). 2023;15(15):3768.","DOI":"10.3390\/cancers15153768"},{"issue":"1","key":"4390_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12957-023-03185-5","volume":"21","author":"J Guo","year":"2023","unstructured":"Guo J, et al. Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy. World J Surg Oncol. 2023;21(1):319.","journal-title":"World J Surg Oncol"},{"issue":"15","key":"4390_CR21","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.2217\/cer-2021-0113","volume":"10","author":"O Abdel-Rahman","year":"2021","unstructured":"Abdel-Rahman O. Outcomes of patients with nonmetastatic gastric adenocarcinoma according to perioperative treatment strategy: a real-world, population-based study. J Comp Eff Res. 2021;10(15):1143\u201351.","journal-title":"J Comp Eff Res"},{"key":"4390_CR22","doi-asserted-by":"publisher","first-page":"1619504","DOI":"10.3389\/fonc.2025.1619504","volume":"15","author":"H Xia","year":"2025","unstructured":"Xia H, et al. Prognostic value of LODDS in late-onset gastric adenocarcinoma: analysis of SEER, TCGA, and external multicenter cohorts. Front Oncol. 2025;15:1619504.","journal-title":"Front Oncol"},{"key":"4390_CR23","doi-asserted-by":"crossref","unstructured":"Zheng H, et al. A machine learning-based predictive model for lymph node metastasis in elderly patients with early gastric cancer and prognosis. Updates Surg. 2025. Epub ahead of print.","DOI":"10.1007\/s13304-025-02471-z"},{"issue":"1","key":"4390_CR24","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s12672-025-03412-3","volume":"16","author":"J Jiao","year":"2025","unstructured":"Jiao J, et al. Nomogram models for predicting lymph node metastasis and prognosis in early gastric cancer 60 or older: a population-based cohort study. Discov Oncol. 2025;16(1):1543.","journal-title":"Discov Oncol"},{"key":"4390_CR25","doi-asserted-by":"crossref","unstructured":"Manceau G et al. Surgical Management of Gastric Cancer in Elderly Patients: Results of a Multicenter Cohort of the French Surgical Association. J Am Coll Surg. 2026;242(1):209\u201322.","DOI":"10.1097\/XCS.0000000000001564"},{"issue":"11","key":"4390_CR26","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1002\/wjs.70118","volume":"49","author":"L Solaini","year":"2025","unstructured":"Solaini L, et al. Enhanced Recovery Protocols in Gastrectomy for Gastric Cancer: Evaluating the Impact of Frailty. World J Surg. 2025;49(11):3217\u201324.","journal-title":"World J Surg"},{"issue":"6","key":"4390_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/ags3.70048","volume":"9","author":"C Tanaka","year":"2025","unstructured":"Tanaka C, et al. Surgery for Older Cancer Patients: Cross-Organ Review and Good Practice Statement by the Japanese Geriatric Oncology Guideline Committee. Ann Gastroenterol Surg. 2025;9(6):1128\u201336.","journal-title":"Ann Gastroenterol Surg"},{"issue":"47","key":"4390_CR28","doi-asserted-by":"publisher","first-page":"113331","DOI":"10.3748\/wjg.v31.i47.113331","volume":"31","author":"JY Li","year":"2025","unstructured":"Li JY, et al. Feasibility and safety of enhanced recovery after surgery in elderly patients with gastric cancer. World J Gastroenterol. 2025;31(47):113331.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4390_CR29","doi-asserted-by":"publisher","first-page":"e2112049","DOI":"10.1001\/jamanetworkopen.2021.12049","volume":"4","author":"D Ramai","year":"2021","unstructured":"Ramai D, et al. Population-Based Long-term Cardiac-Specific Mortality Among Patients With Major Gastrointestinal Cancers. JAMA Netw Open. 2021;4(6):e2112049.","journal-title":"JAMA Netw Open"},{"issue":"19","key":"4390_CR30","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","volume":"17","author":"RB D\u2019Agostino Jr","year":"1998","unstructured":"D\u2019Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265\u201381.","journal-title":"Stat Med"},{"issue":"3","key":"4390_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"6","key":"4390_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/aje\/kwn164","volume":"168","author":"SR Cole","year":"2008","unstructured":"Cole SR, Hern\u00e1n MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656\u201364.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"4390_CR33","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/ijc.35489","volume":"157","author":"Z Pelc","year":"2025","unstructured":"Pelc Z, et al. Impact of prognostic nutritional index on oncological outcomes and mortality among advanced gastric cancer patients: European GASTRODATA registry analysis. Int J Cancer. 2025;157(8):1734\u201345.","journal-title":"Int J Cancer"},{"key":"4390_CR34","doi-asserted-by":"crossref","unstructured":"Jeong SA, Kim S, Kim JH. Prognostic significance of extranodal extension for early postoperative recurrence following curative surgery in advanced gastric cancer. Surg Endosc. 2026;40(2):1256\u201365.","DOI":"10.1007\/s00464-025-12372-2"},{"key":"4390_CR35","doi-asserted-by":"crossref","unstructured":"Zhang D et al. Timing and clinical significance of chemotherapy in patients with resected gastric adenocarcinoma: a population-based cohort study. Oncologist. 2025;30(7):oyaf179.","DOI":"10.1093\/oncolo\/oyaf179"},{"key":"4390_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.suronc.2020.04.010","volume":"34","author":"AM Altman","year":"2020","unstructured":"Altman AM, et al. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer. Surg Oncol. 2020;34:134\u20139.","journal-title":"Surg Oncol"},{"issue":"12","key":"4390_CR37","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1245\/s10434-017-6048-3","volume":"24","author":"VKY Ho","year":"2017","unstructured":"Ho VKY, et al. Adjuvant Chemoradiotherapy for Non-Pretreated Gastric Cancer. Ann Surg Oncol. 2017;24(12):3647\u201357.","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04390-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04390-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04390-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:01:08Z","timestamp":1783051268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04390-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4390"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04390-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available, de-identified SEER data and therefore did not involve direct human participant contact. According to local institutional policy, formal ethics review and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}